Skip to content



Open Access

Determining items for inclusion in a decision support intervention for clinical trial participation: a modified Delphi approach

  • Katie Gillies1,
  • Zoe Skea1, 2,
  • Sara MacLennan2,
  • Craig Ramsay1 and
  • Marion Campbell1
Trials201314(Suppl 1):O64

Published: 29 November 2013


Decision SupportStakeholder GroupSupport InterventionResearch NurseDecision Support Tool

The use of decision aids in the context of decisions about trial participation is an emergent field. There is a lack of evidence about what information different stakeholders deem important for decisions about informed consent for clinical trials, and whether different groups agree on information. Therefore, the objective of this study was to determine items that different stakeholder groups view to be important for inclusion in a decision support tool for clinical trial participation; with a view to use these as a framework for developing decision support tools in this context.

A modified Delphi method was used to determine agreement on importance of items. The ‘expert' panel was made up of 49 individuals from 5 groups: 11 trialists; 6 research nurses; 7 ethics committee chairs; 9 decision support experts and 16 patients (9 trial experienced and 7 trial non-experienced). Two rounds of rating were completed. Items with a median of 7-10 with ≥65% of any one group in agreement were considered important for inclusion.

The expert panel achieved consensus on the majority of items included (60/66), agreeing that these were important for inclusion in a decision support tool for trial participation. These included items covering: information about trial participation and standard care; information on the likelihood of receiving different treatments; information to help patients' determine what matters most to them; ensuring the information is balanced; guidance on how to make a decision; disclosure of any conflicts of interest; using plain language in the tool and guidance on the development process Some areas of divergence amongst the panel were also identified relating to the use of patient stories.

Agreement was obtained on a number of items, which could be used as a framework to develop tools to support decision making about participation in clinical trials.

Authors’ Affiliations

Health Services Research Unit, University of Aberdeen, Aberdeen, UK
Academic Urology Unit, University of Aberdeen, Aberdeen, UK


© Gillies et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.